Avid Bioservices, Inc., a dedicated biologics CDMO, has appointed Elie G. Hanania, Ph.D., as vice president, process development, viral vector technologies. Dr. Hanania is an experienced life science industry executive with more than 30 years of experience in the field of cell and gene therapy.  Avid recently announced the expansion of its CDMO service offering into the rapidly growing cell and gene therapy market and Dr. Hanania will be responsible for leading the company’s efforts in this area...